Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis Through Circulating Tumor Cells

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 May 11

PMID 38732051

Authors

Amalia Kotsifaki

Sousanna Maroulaki

Athanasios Armakolas

Affiliations

Soon will be listed here.

Abstract

This review offers a comprehensive exploration of the intricate immunological landscape of breast cancer (BC), focusing on recent advances in diagnosis and prognosis through the analysis of circulating tumor cells (CTCs). Positioned within the broader context of BC research, it underscores the pivotal role of the immune system in shaping the disease's progression. The primary objective of this investigation is to synthesize current knowledge on the immunological aspects of BC, with a particular emphasis on the diagnostic and prognostic potential offered by CTCs. This review adopts a thorough examination of the relevant literature, incorporating recent breakthroughs in the field. The methodology section succinctly outlines the approach, with a specific focus on CTC analysis and its implications for BC diagnosis and prognosis. Through this review, insights into the dynamic interplay between the immune system and BC are highlighted, with a specific emphasis on the role of CTCs in advancing diagnostic methodologies and refining prognostic assessments. Furthermore, this review presents objective and substantiated results, contributing to a deeper understanding of the immunological complexity in BC. In conclusion, this investigation underscores the significance of exploring the immunological profile of BC patients, providing valuable insights into novel advances in diagnosis and prognosis through the utilization of CTCs. The objective presentation of findings emphasizes the crucial role of the immune system in BC dynamics, thereby opening avenues for enhanced clinical management strategies.

Citing Articles

Current advancement of immune function paradox of tumour-infiltrating cells and their immunotherapeutic targets: a mini-review.

Tom V, Jose A, Mallick S, Sasidharan A, Pawar R, Somayaji Y Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40063239 DOI: 10.1007/s00210-025-03985-4.

Decoding the Role of Insulin-like Growth Factor 1 and Its Isoforms in Breast Cancer.

Kotsifaki A, Maroulaki S, Karalexis E, Stathaki M, Armakolas A Int J Mol Sci. 2024; 25(17).

PMID: 39273251 PMC: 11394947. DOI: 10.3390/ijms25179302.

References

Melo Garcia L, Barabe F . Harnessing Macrophages through the Blockage of CD47: Implications for Acute Myeloid Leukemia. Cancers (Basel). 2021; 13(24). PMC: 8699809. DOI: 10.3390/cancers13246258. View

Aceto N, Bardia A, Miyamoto D, Donaldson M, Wittner B, Spencer J . Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158(5):1110-1122. PMC: 4149753. DOI: 10.1016/j.cell.2014.07.013. View

Sher G, Salman N, Khan A, Prabhu K, Raza A, Kulinski M . Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications. Semin Cancer Biol. 2020; 83:152-165. DOI: 10.1016/j.semcancer.2020.08.009. View

Visal T, den Hollander P, Cristofanilli M, Mani S . Circulating tumour cells in the -omics era: how far are we from achieving the 'singularity'?. Br J Cancer. 2022; 127(2):173-184. PMC: 9296521. DOI: 10.1038/s41416-022-01768-9. View

Bidard F, Proudhon C, Pierga J . Circulating tumor cells in breast cancer. Mol Oncol. 2016; 10(3):418-30. PMC: 5528978. DOI: 10.1016/j.molonc.2016.01.001. View

Campton D, Ramirez A, Nordberg J, Drovetto N, Clein A, Varshavskaya P . High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining. BMC Cancer. 2015; 15:360. PMC: 4430903. DOI: 10.1186/s12885-015-1383-x. View

Chehelgerdi M, Chehelgerdi M, Allela O, Pecho R, Jayasankar N, Rao D . Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023; 22(1):169. PMC: 10561438. DOI: 10.1186/s12943-023-01865-0. View

Stoecklein N, Oles J, Franken A, Neubauer H, Terstappen L, Neves R . Clinical application of circulating tumor cells. Med Genet. 2024; 35(4):237-250. PMC: 11110132. DOI: 10.1515/medgen-2023-2056. View

Cole K, Al-Kadhimi Z, Talmadge J . Role of myeloid-derived suppressor cells in tumor recurrence. Cancer Metastasis Rev. 2023; 42(1):113-142. PMC: 9840433. DOI: 10.1007/s10555-023-10079-1. View

10.

Pimentel J, Zhou J, Wu G . The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer. Cancers (Basel). 2023; 15(10). PMC: 10216286. DOI: 10.3390/cancers15102752. View

11.

Nguyen T, Huang P, Chu P, Hsieh C, Wu M . Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters. Cancers (Basel). 2023; 15(22). PMC: 10670359. DOI: 10.3390/cancers15225372. View

12.

Rzhevskiy A, Kapitannikova A, Malinina P, Volovetsky A, Aboulkheyr Es H, Kulasinghe A . Emerging role of circulating tumor cells in immunotherapy. Theranostics. 2021; 11(16):8057-8075. PMC: 8315079. DOI: 10.7150/thno.59677. View

13.

Munoz-Arcos L, Nicolo E, Serafini M, Gerratana L, Reduzzi C, Cristofanilli M . Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer. Int Rev Cell Mol Biol. 2023; 381:1-21. DOI: 10.1016/bs.ircmb.2023.07.005. View

14.

Goff S, Danforth D . The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer. Clin Breast Cancer. 2020; 21(1):e63-e73. PMC: 7775885. DOI: 10.1016/j.clbc.2020.06.011. View

15.

Li X, Li Y, Shao W, Li Z, Zhao R, Ye Z . Strategies for enrichment of circulating tumor cells. Transl Cancer Res. 2022; 9(3):2012-2025. PMC: 8797280. DOI: 10.21037/tcr.2020.01.17. View

16.

Yi M, Li T, Niu M, Mei Q, Zhao B, Chu Q . Exploiting innate immunity for cancer immunotherapy. Mol Cancer. 2023; 22(1):187. PMC: 10680233. DOI: 10.1186/s12943-023-01885-w. View

17.

Gorges T, Stein A, Quidde J, Hauch S, Rock K, Riethdorf S . Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®. PLoS One. 2016; 11(5):e0155126. PMC: 4868337. DOI: 10.1371/journal.pone.0155126. View

18.

Baxevanis C, Fortis S, Perez S . The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies. Semin Cancer Biol. 2019; 72:76-89. DOI: 10.1016/j.semcancer.2019.12.018. View

19.

Schneider B, Shen F, Jiang G, ONeill A, Radovich M, Li L . Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103. JCO Precis Oncol. 2018; 2017. PMC: 5765553. DOI: 10.1200/PO.17.00059. View

20.

Bates M, Mohamed B, Ward M, Kelly T, OConnor R, Malone V . Circulating tumour cells: The Good, the Bad and the Ugly. Biochim Biophys Acta Rev Cancer. 2023; 1878(2):188863. DOI: 10.1016/j.bbcan.2023.188863. View